A genetic medicines company is reducing its headcount. The company is cutting its workforce by 50%. This action aims to preserve cash. It is awaiting data for a bladder-cancer gene therapy dr-g. The headcount reduction occurs during this waiting period.
https://www.bizjournals.com/boston/news/2026/06/16/engene-slashes-staff-by-50.html